NEXGEL, Inc. Announces Resignation of David Stefansky as Member of the Board of Directors
December 12, 2023 at 04:52 pm
Share
On December 7, 2023, David Stefansky notified NexGel, Inc. of his intent to resign as a member of the Company's Board of Directors (the Board") effective as of December 31, 2023 to pursue other business ventures. Mr. Stefansky is the Chairperson of the Board's Compensation Committee and a member of Nominating and Corporate Governance Committee. The Company wishes to thank Mr. Stefansky for his dedicated and important
service as a member of the Board. Mr. Stefansky's resignation is not as a result of any disagreement with the Company or any of its subsidiaries on any matters related to their operation, policies or practices.
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Companyâs converting and packaging business, which is based in Granbury, Texas. All of its gel products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty.
NEXGEL, INC. 
